![](https://meta-bolism.com/wp-content/uploads/2021/09/wegovy.jpg)
彙整
頁次 2/25
![](https://meta-bolism.com/wp-content/uploads/2021/09/wegovy.jpg)
![](https://meta-bolism.com/wp-content/uploads/2023/10/cycling-400x200.png)
透過運動達到打減肥針(GLP-1)的效果
![](https://meta-bolism.com/wp-content/uploads/2023/10/hypertension-400x200.png)
最新高血壓診斷標準、檢測與控制
![](https://meta-bolism.com/wp-content/uploads/2023/08/adult-suffering-from-social-media-addiction-scaled.jpeg)
內分泌新陳代謝相關的睡眠障礙
![](https://meta-bolism.com/wp-content/uploads/2023/08/Retatrutide-400x200.png)
3G減肥時代將來臨!三重激素受體刺激劑瑞他魯肽Retatrutide第二期臨床研究證實可減少體重達17.5%!
![](https://meta-bolism.com/wp-content/uploads/2023/08/MASLD1-400x200.jpeg)
「非酒精性脂肪肝(NAFLD)」現在將被稱為「代謝功能障礙相關脂肪肝病(MASLD)」
![](https://meta-bolism.com/wp-content/uploads/2023/07/2022台灣高風險病人血脂指引更新1-400x200.jpeg)
2022台灣高風險病人血脂指引更新
![](https://meta-bolism.com/wp-content/uploads/2013/02/GLP-1-weight-loss.jpg)
減肥藥物引發自殺意念,還是減肥本身引發自殺意念,談最近GLP-1受體致效劑在歐盟開始展開會否引發自殺的調查
![](https://meta-bolism.com/wp-content/uploads/2023/07/CagriSema1-400x200.png)
強強聯合+長長聯合!每週一次卡格林肽cagrilintide 2.4 毫克,與每週一次索馬魯肽semaglutide 2.4 毫克聯合治療(CagriSema),證實可有效控制糖胖症,體重下降幅度達–15·6%
![](https://meta-bolism.com/wp-content/uploads/2020/02/Rybelsus.jpg)